1. GPCR/G Protein MAPK/ERK Pathway PI3K/Akt/mTOR Stem Cell/Wnt
  2. Ras Akt Raf ERK
  3. KRAS-IN-58

KRAS-IN-58 is a KRAS inhibitor with a IC50 of 0.223 μM against KRASG12D. KRAS-IN-58 binds to KRASG12C and KRASG12D proteins, and reduces the levels of phosphorylated Raf1, AKT and ERK in pancreatic cancer cells. KRAS-IN-58 can be used for the research of pancreatic cancer.

For research use only. We do not sell to patients.

KRAS-IN-58

KRAS-IN-58 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Ras Isoform Specific Products:

View All Akt Isoform Specific Products:

View All Raf Isoform Specific Products:

View All ERK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

KRAS-IN-58 is a KRAS inhibitor with a IC50 of 0.223 μM against KRASG12D. KRAS-IN-58 binds to KRASG12C and KRASG12D proteins, and reduces the levels of phosphorylated Raf1, AKT and ERK in pancreatic cancer cells. KRAS-IN-58 can be used for the research of pancreatic cancer[1].

IC50 & Target[1]

KRas G12D

223 nM (IC50)

In Vitro

KRAS-IN-58 (Compound 10b) (24 h) inhibits viability of ASPC-1, PANC-1, and Miapac-2 pancreatic cancer cells with IC50 values of 1.16 μM, 6.59 μM, and 6.432 μM, respectively[1].
KRAS-IN-58 (24 h) inhibits viability of SW1990 pancreatic cancer cells with an IC50 of 1.518 μM, while showing much weaker activity against LO2 normal hepatic cells (IC50 = 55.53 μM) and HPDE6-C7 normal pancreatic epithelial cells (IC50 = 10.50 μM), demonstrating selective activity for cancerous over non-cancerous cells[1].
pan-KRAS-IN-19 (1.25-20 μM) dose-dependently downregulates levels of KRAS, pRaf1, pAKT, and pERK in ASPC-1 and Miapac-2 pancreatic cancer cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Parmacokinetics
Species Dose Route T1/2 Tmax Cmax MRT CL Vss Vz AUC
Mice[1] 2 mg/kg i.v. 4.3 h / / 0.512 h 66 mL/min/kg 2.6 L/kg 26 L/kg 510 ng·h/mL
Mice[1] 10 mg/kg p.o. 6.52 h 0.333 h 1.4 ng/mL 2.82 h / / / /
Molecular Weight

451.52

Formula

C21H17N5O3S2

SMILES

CN1C=CC=C1/C=C2SC(N(C\2=O)CCSC3=NN=C(O3)C4=CNC5=C4C=CC=C5)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
KRAS-IN-58
Cat. No.:
HY-182749
Quantity:
MCE Japan Authorized Agent: